Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Vaccines is Scopus-indexed (Q1, CiteScore 7.7), WoS SCIE, DOAJ. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2076-393XVerify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 53 / 361 | 85th | Q1 |
| Pharmacology (medical) | 44 / 278 | 84th | Q1 |
| Pharmacology | 69 / 328 | 79th | Q1 |
| Drug Discovery | 38 / 161 | 76th | Q1 |
| Immunology | 63 / 243 | 74th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 7.7.
Vaccines is Q1 in Infectious Diseases (rank 53 of 361), Q1 in Pharmacology (medical) (rank 44 of 278) and Q1 in Pharmacology (rank 69 of 328), by CiteScore 2025. It is ranked in 5 subject areas in all.
Vaccines is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.7, which places it in quartile Q1 at the 85th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.955, quartile Q1, with an H-index of 111.
The publisher lists an article processing charge of about US$3,258 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Vaccines is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2076-393X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Vaccines has an h-index of 136 and a 2-year mean of 4.33 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #43 of 354 Scopus journals in Infectious Diseases.
Vaccines published 1,278 papers in 2025; its busiest recent year was 2022 with 2,216. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2026), authors are most often from China (15.5%), United States (14.9%) and Italy (7.3%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (0.6 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.